Hum. Reprod. Advance Access published online on July 16, 2009
Human Reproduction, doi:10.1093/humrep/dep256
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Opinion |
Do etiologies of premature ovarian aging (POA) mimic those of premature ovarian failure (POF)?
1 Center for Human Reproduction, 21 East 69th Street, New York, NY 10021, USA 2 Foundation for Reproductive Medicine, New York, NY, USA 3 Department of Obstetrics, Gynecology and Reproductive Sciences, Yale University School of Medicine, New Haven, CT, USA 4 Department of Obstetrics and Gynecology, Vienna University School of Medicine, Vienna, Austria 5 Department of Obstetrics and Gynecology, New York Medical College, Valhalla, NY, USA 6 Department of Epidemiology and Social Medicine, Albert Einstein College of Medicine, Bronx, NY, USA 7 Department of Obstetrics, Gynecology and Women's Health, Albert Einstein College of Medicine, Bronx, NY, USA
8 Corresponding author. Tel: +1-212-994-4400; Fax: +1-212-994-4499; E-mail: ngleicher{at}thechr.com
BACKGROUND: It is unknown whether etiologies differ between milder forms of premature ovarian senescence (the acronym given here premature ovarian aging, POA), and premature ovarian failure (POF).
METHODS: We assessed presumed pathophysiologies in 74 consecutive POA patients, diagnosed based on elevated age-specific baseline follicle stimulating hormone and/or abnormally low anti-Müllerian hormone levels (<1.5 ng/ml). A genetic etiology was presumed with
34 triple CGG expansions on the FMR1 gene. An autoimmune etiology was assumed with at least one abnormality in a laboratory panel, involving antinuclear, antiphospholipid and thyroid antibodies, total immunoglobulin levels and anti-ovarian as well as anti-adrenal autoantibodies. A combined etiology was presumed with both autoimmune and genetic etiologies, and a patient was considered idiopathic when no abnormalities were found.
RESULTS: Twelve of 74 (16.2%) women demonstrated a genetic, 28 (37.8%) an autoimmune, 9 (12.2%) combined and 25 (33.8%) idiopathic etiologies.
CONCLUSIONS: Presumed underlying etiologies with POA follow a similar distribution pattern as reported for POF. POA and POF may, therefore, represent a continuum in phenotypical expression of different etiologies of premature ovarian senescence. Like POF, POA should be considered reason to investigate underlying etiologies.
Key words: diminished ovarian reserve/premature ovarian failure (POF)/premature ovarian aging (POA)/FMR1 gene/autoimmunity